A study of the possible neuroprotective effects of simvastatin and curcumin in l-methionine-induced vascular dementia in rats /
Ahmed Mohamed Eldesoky Youssef
A study of the possible neuroprotective effects of simvastatin and curcumin in l-methionine-induced vascular dementia in rats / دراسة لتأثيرات الوقاية العصبية المحتملة لكل من سيمفاستاتين و الكركمين في الخرف الوعائي الذي يسببه ل-ميثيونين في الجرذان Ahmed Mohamed El Desoky Youssef ; Supervised Hala Fahmy Zaki , Azza Sayed Awad , May A. Galal - Cairo : Ahmed Mohamed Eldesoky Youssef , 2016 - 212 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
Vascular dementia (VaD) is a degenerative cerebrovascular disorder that leads to progressive decline in cognitive abilities and memory. Several reports demonstrated that oxidative stress and endothelial dysfunction are principal pathogenic factors in VaD. The present study was constructed to determine the possible neuroprotective effects of simvastatin and curcumin in comparison with cilostazol in VaD induced by l-methionine in rats. Male Wistar rats were divided into five groups. Group I (control group), group II received l-methionine (1.7g/kg, p.o.) for 32 days. The remaining three groups received simvastatin (50 mg/kg, p.o.), curcumin (300mg/kg, p.o.) and cilostazol (100 mg/kg, p.o.), respectively for 32 days after induction of VaD by l-methionine. Subsequently, rats were tested for cognitive performance using Morris water maze test then sacrificed for biochemical and histopathological assays. L-methionine induced VaD reflected by alterations in rats' behavior as well as the estimated neurotransmitters, acetylcholinesterase activity, as well as, increased brain oxidative stress and inflammation parallel to histopathological changes in brain tissue. Treatment of rats with simvastatin or curcumin ameliorated l-methionine-induced behavioral, neurochemical and histological changes in a manner comparable to cilostazol. Simvastatin or curcumin may be regarded as a potential therapeutic strategy for the treatment of VaD
L-methionine Simvastatin Vascular dementia
A study of the possible neuroprotective effects of simvastatin and curcumin in l-methionine-induced vascular dementia in rats / دراسة لتأثيرات الوقاية العصبية المحتملة لكل من سيمفاستاتين و الكركمين في الخرف الوعائي الذي يسببه ل-ميثيونين في الجرذان Ahmed Mohamed El Desoky Youssef ; Supervised Hala Fahmy Zaki , Azza Sayed Awad , May A. Galal - Cairo : Ahmed Mohamed Eldesoky Youssef , 2016 - 212 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
Vascular dementia (VaD) is a degenerative cerebrovascular disorder that leads to progressive decline in cognitive abilities and memory. Several reports demonstrated that oxidative stress and endothelial dysfunction are principal pathogenic factors in VaD. The present study was constructed to determine the possible neuroprotective effects of simvastatin and curcumin in comparison with cilostazol in VaD induced by l-methionine in rats. Male Wistar rats were divided into five groups. Group I (control group), group II received l-methionine (1.7g/kg, p.o.) for 32 days. The remaining three groups received simvastatin (50 mg/kg, p.o.), curcumin (300mg/kg, p.o.) and cilostazol (100 mg/kg, p.o.), respectively for 32 days after induction of VaD by l-methionine. Subsequently, rats were tested for cognitive performance using Morris water maze test then sacrificed for biochemical and histopathological assays. L-methionine induced VaD reflected by alterations in rats' behavior as well as the estimated neurotransmitters, acetylcholinesterase activity, as well as, increased brain oxidative stress and inflammation parallel to histopathological changes in brain tissue. Treatment of rats with simvastatin or curcumin ameliorated l-methionine-induced behavioral, neurochemical and histological changes in a manner comparable to cilostazol. Simvastatin or curcumin may be regarded as a potential therapeutic strategy for the treatment of VaD
L-methionine Simvastatin Vascular dementia